Watch this on-demand webcast from a satellite symposia at the 2021 Hematology meeting to learn from the experts how to use biomarkers in the diagnosis and selection of therapy for TCL, including future directions and key ongoing trials.
Read this commentary from lymphoma expert Steven M. Horwitz, MD, on the current approach for characterization and management of T-cell lymphomas using biomarkers and targeted therapies.
Download this short summary slideset of key takeaway points from a CCO live symposium on biomarker-driven therapies for T-cell lymphomas.
Download these slides from an ASH satellite symposium to learn how to optimally manage PTCL and ALCL subtypes of lymphoma using biomarkers and targeted therapy.
Download these slides from an ASH satellite symposium to learn how to improve outcomes for relapsed/refractory PTCL using biomarkers and targeted therapy.
Download these slides from an ASH satellite symposium to learn about systemic treatments for cutaneous T-cell lymphomas using biomarkers and targeted therapy.
In this podcast episode, listen to Steven M. Horwitz, MD; Francine Foss, MD; and Barbara Pro, MD, answer questions from an audience of healthcare professionals on managing patients with T-cell lymphoma using biomarker-driven therapies.
Download this short summary of key points from a FAQ podcast on managing patients with T-cell lymphomas using biomarker-driven therapies and the latest clinical evidence.
Download this PDF guide to best practices for optimal team management of patients with T-cell lymphomas with biomarker-driven therapies.